| Role |
Name |
Disclosure |
Details |
| Author | Noah S Scheinfeld, MD, JD, FAAD, Assistant Clinical Professor, Department of Dermatology, Columbia University; Consulting Staff, Department of Dermatology, St Luke's Roosevelt Hospital Center, Beth Israel Medical Center, New York Eye and Ear Infirmary; Private Practice | Optigenex | Details | | Coauthor | Melanie K Kuechle, MD, Assistant Professor, Department of Medicine, Division of Dermatology, University of Washington School of Medicine | Nothing to disclose | Details | | Medical Editor | Evan R Farmer, MD, Professor of Dermatology, Johns Hopkins University School of Medicine, Clinical Professor of Pathology, Virginia Commonwealth University School of Medicine; Consulting Staff, Department of Dermatology, Johns Hopkins Hospital, VCU Health Services | Nothing to disclose | Details | | Pharmacy Editor | Michael J Wells, MD, Associate Professor, Department of Dermatology, Texas Tech University Health Sciences Center | Nothing to disclose | Details | | Managing Editor | Warren R Heymann, MD, Head, Division of Dermatology, Professor, Department of Internal Medicine, University of Medicine and Dentistry of New Jersey | Nothing to disclose | Details | | CME Editor | Catherine Quirk, MD, Clinical Assistant Professor, Department of Dermatology, Brown University | Nothing to disclose | Details | | Chief Editor | Dirk M Elston, MD, Director, Department of Dermatology, Geisinger Medical Center | Nothing to disclose | Details |
Contributor Disclosure
Contributor:
|
Contributor Disclosure: |
| Melanie K Kuechle, Coauthor |
The contributor discloses no conflict of interest. |
Contributor Disclosure
Contributor:
|
Contributor Disclosure: |
| Warren R Heymann, Managing Editor |
The contributor discloses no conflict of interest. |
|